Literature DB >> 1698771

The alpha 1 chain of type XIII collagen consists of three collagenous and four noncollagenous domains, and its primary transcript undergoes complex alternative splicing.

T Pihlajaniemi1, M Tamminen.   

Abstract

We have recently reported a characterization of cDNA clones that encode an apparently novel human collagen that undergoes alternative splicing. These cDNAs covered one-third of the corresponding 2.5-2.8-kilobase mRNAs. We have now determined the complete primary structure of the protein encoded by several overlapping cDNAs isolated from a human endothelial cell library. Since the deduced translation product of the cDNAs is different in structure from all other collagen types, we have given the collagen chain encoded by the cDNAs the designation alpha 1 (XIII). The deduced polypeptide consists of three collagenous domains and four noncollagenous domains, two of them separating the collagenous domains and two located at the N-terminal and C-terminal ends of the polypeptide. Cysteine residues are found in three of the noncollagenous domains and also in the extreme N-terminal collagenous domain. Surprisingly, comparison of the nucleotide sequences encoded by the overlapping cDNA clones demonstrates that there are several alpha 1 (XIII) collagen mRNAs in HT-1080 human fibrosarcoma cells and human endothelial cells which differ in coding potential. Nuclease S1 mapping experiments suggest that these different mRNAs arise through alternative splicing of the precursor RNA at five locations within the coding region. This property makes type XIII collagen unique among all the collagen types studied so far. Its polypeptide length, therefore, may vary between 614 and 526 amino acids, depending on what internal splicing has taken place.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins.

Authors:  A Snellman; H Tu; T Väisänen; A P Kvist; P Huhtala; T Pihlajaniemi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

2.  A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis.

Authors:  K A Spivey; I Chung; J Banyard; I Adini; H A Feldman; B R Zetter
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

3.  The shed ectodomain of type XIII collagen associates with the fibrillar fibronectin matrix and may interfere with its assembly in vitro.

Authors:  Marja-Riitta Väisänen; Timo Väisänen; Hongmin Tu; Päivi Pirilä; Raija Sormunen; Taina Pihlajaniemi
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen.

Authors:  M Rehn; T Pihlajaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  Characterization of an intronless collagen gene family in the marine sponge Microciona prolifera.

Authors:  S Aho; H Turakainen; M L Onnela; H Boedtker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Probing the human natural autoantibody repertoire using an immunoscreening approach.

Authors:  N Comtesse; D Heckel; E Maldener; B Glass; E Meese
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

7.  Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen.

Authors:  M Sund; R Ylönen; A Tuomisto; R Sormunen; J Tahkola; A P Kvist; S Kontusaari; H Autio-Harmainen; T Pihlajaniemi
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

8.  Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy.

Authors:  A P Kvist; A Latvanlehto; M Sund; L Eklund; T Väisänen; P Hägg; R Sormunen; J Komulainen; R Fässler; T Pihlajaniemi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

9.  Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region.

Authors:  J C Myers; S Kivirikko; M K Gordon; A S Dion; T Pihlajaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.

Authors:  Clare V Logan; Judith Cossins; Pedro M Rodríguez Cruz; David A Parry; Susan Maxwell; Pilar Martínez-Martínez; Joey Riepsaame; Zakia A Abdelhamed; Alice V R Lake; Maria Moran; Stephanie Robb; Gabriel Chow; Caroline Sewry; Philip M Hopkins; Eamonn Sheridan; Sandeep Jayawant; Jacqueline Palace; Colin A Johnson; David Beeson
Journal:  Am J Hum Genet       Date:  2015-11-25       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.